Pancreatic Cancer Research

ResearcherZhejiang Chinese Medical UniversityActive in the last 2 years

Rong Dong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2372-9833; OpenAlex author ID A5029304304. Sources: OpenAlex.

Their work

Papers
3 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 3

  1. The Effect of AZD5153 on Radiosensitivity in Pancreatic Cancer Cells Through ATM-chk1 Pathway. First author DOI 10.2147/dddt.s568551↗
  2. AZD5153 enhances the chemo-sensitivity of gemcitabine on pancreatic cancer cells in vitro and in vivo. Last author DOI 10.1186/s12935-025-03952-2↗
  3. The Ibr-7 derivative of ibrutinib radiosensitizes pancreatic cancer cells by downregulating p-EGFR. First author DOI 10.1186/s12935-020-01548-6↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lulin Zhu · 2 shared papers, 2025–2026 · strength 0.53
  2. Nengming Lin · 2 shared papers, 2020–2025 · strength 0.36
  3. Biqin Tan · 2 shared papers, 2020–2025 · strength 0.36
  4. Youyou Yan · 2 shared papers, 2020–2025 · strength 0.36
  5. Bei Tan · 1 shared paper, 2026 · strength 0.30
  6. Nengming Lin · 1 shared paper, 2026 · strength 0.30
  7. Bo Zhang · 1 shared paper, 2025 · strength 0.23
  8. Fei Wang · 1 shared paper, 2020 · strength 0.13
  9. Bo Zhang · 1 shared paper, 2020 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.